Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study
Open Access
- 30 October 2012
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 134
Abstract
Patients with hypertension and cardiovascular disease (CVD), diabetes, or chronic kidney disease (CKD) usually require two or more antihypertensive agents to achieve blood pressure (BP) goals.Keywords
This publication has 45 references indexed in Scilit:
- What is a preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment?Cardiovascular Diabetology, 2012
- Implications of New Hypertension Guidelines in the United StatesHypertension, 2011
- ACCF/AHA/AMA–PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and HypertensionJACC, 2011
- Adherence to Antihypertensive Agents and Blood Pressure Control in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2010
- Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery DiseaseJAMA, 2010
- Treatment of hypertension in patients with diabetes—an updateJournal of the American Society of Hypertension, 2010
- Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive AgentsHypertension, 2010
- Combination therapy in hypertensionJournal of the American Society of Hypertension, 2010
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudyAmerican Heart Journal, 2008